Results 271 to 280 of about 654,309 (397)

Outcomes associated with use of makyokansekito, a Japanese herbal kampo medicine, in outpatients with community‐acquired pneumonia: A retrospective cohort study

open access: yesJournal of General and Family Medicine, Volume 26, Issue 5, Page 427-434, September 2025.
Abstract Introduction Although selected patients with community‐acquired pneumonia (CAP) can be treated in outpatient settings, some exhibit an insufficient response to initial outpatient treatment resulting in subsequent hospitalizations. Laboratory and animal studies have demonstrated that makyokansekito, a Japanese herbal kampo medicine, can ...
Yuichiro Matsuo   +2 more
wiley   +1 more source

Spatial transcriptomics identifies SPARC as a prognostic marker in interstitial lung diseases

open access: yesThe Journal of Pathology, Volume 267, Issue 1, Page 79-91, September 2025.
Abstract Interstitial lung diseases (ILDs) encompass a diverse group of pulmonary disorders, with progressive fibrosis leading to poor prognosis. Here we aimed to identify key molecules involved in progressive fibrosis across various ILDs, using spatial transcriptomics (ST).
Takayuki Niitsu   +13 more
wiley   +1 more source

Anti-neutrophil cytoplasmic antibodies associated interstitial pneumonia: A possible new clinical entity. [PDF]

open access: yesEur J Clin Invest
Iannone C   +11 more
europepmc   +1 more source

Serum Levels of KL-6 Reflect Disease Activity of Interstitial Pneumonia Associated with ANCA-related Vasculitis.

open access: bronze, 2001
Yasunori Iwata   +10 more
openalex   +2 more sources

Microbiota diversity and differences in the respiratory tract of children with pneumonia

open access: yesPediatric Investigation, Volume 9, Issue 3, Page 262-274, September 2025.
Differences in microbial communities in the upper and lower respiratory tract in patients with pneumonia were investigated in this study by sequencing the 16S rRNA genes in pharyngeal swabs and alveolar lavage fluid. Forty‐three subjects were enrolled in the study, and one upper and one lower respiratory tract sample were collected from each subject ...
Dandan Ge   +4 more
wiley   +1 more source

Asbestosis and environmental causes of usual interstitial pneumonia

open access: yesCurrent opinion in pulmonary medicine, 2015
M. Gulati, C. Redlich
semanticscholar   +1 more source

Low‐dose versus high‐dose methylprednisolone for children with severe Mycoplasma pneumoniae pneumonia (MCMP): A randomized controlled trial

open access: yesPediatric Investigation, Volume 9, Issue 3, Page 251-261, September 2025.
Although macrolides combined with glucocorticoids can prevent long‐term pulmonary lesions by severe Mycoplasma pneumoniae pneumonia (MPP), evidence regarding glucocorticoid dose is lacking. We found that high‐dose methylprednisolone compared to low‐dose did not reduce long‐term pulmonary lesions of severe MPP in Chinese children, but significantly ...
Baoping Xu   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy